We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$429M
AUM Growth
+$8.73M
Cap. Flow
-$4.07M
Cap. Flow %
-0.95%
Top 10 Hldgs %
33.96%
Holding
360
New
39
Increased
44
Reduced
62
Closed
23

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.28M
2
TER icon
Teradyne
TER
+$2.82M
3
FCX icon
Freeport-McMoran
FCX
+$2.73M
4
MU icon
Micron Technology
MU
+$1.94M
5
PH icon
Parker-Hannifin
PH
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 20.35%
2 Healthcare 17.84%
3 Industrials 12.94%
4 Financials 12.24%
5 Energy 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
201
FedEx
FDX
$74.3B
$22.3K 0.01%
90
SPRO icon
202
Spero Therapeutics
SPRO
$68.9M
$21.9K 0.01%
15,100
-10,500
-41% -$18K
QQQ icon
203
Invesco QQQ Trust
QQQ
$482B
$21.8K 0.01%
59
IYW icon
204
iShares US Technology ETF
IYW
$25B
$21.8K 0.01%
200
SCCO icon
205
Southern Copper
SCCO
$162B
$21.7K 0.01%
327
DD icon
206
DuPont de Nemours
DD
$18.9B
$21.7K 0.01%
242
MDY icon
207
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$21.6K 0.01%
45
CL icon
208
Colgate-Palmolive
CL
$72.9B
$21.5K 0.01%
279
+2
+0.7% +$155
RSPH icon
209
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$772M
$20.9K ﹤0.01%
700
DMXF icon
210
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.01B
$20.7K ﹤0.01%
+340
New +$20.6K
ORMP icon
211
Oramed Pharmaceuticals
ORMP
$175M
$20.1K ﹤0.01%
5,627
LIT icon
212
Global X Lithium & Battery Tech ETF
LIT
$1.55B
$19.8K ﹤0.01%
305
BCI icon
213
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.9B
$19.5K ﹤0.01%
+966
New +$19.7K
VIG icon
214
Vanguard Dividend Appreciation ETF
VIG
$113B
$19.2K ﹤0.01%
118
ESML icon
215
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.91B
$18.8K ﹤0.01%
+530
New +$17.9K
PPG icon
216
PPG Industries
PPG
$26.1B
$18.5K ﹤0.01%
125
ESGU icon
217
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
$18K ﹤0.01%
+185
New +$17.1K
RF icon
218
Regions Financial
RF
$27.2B
$17.8K ﹤0.01%
1,000
MNST icon
219
Monster Beverage
MNST
$91B
$17.2K ﹤0.01%
300
MS icon
220
Morgan Stanley
MS
$343B
$17.1K ﹤0.01%
200
-100
-33% -$8.55K
CHD icon
221
Church & Dwight Co
CHD
$24.1B
$17K ﹤0.01%
170
+1
+0.6% +$94
PPA icon
222
Invesco Aerospace & Defense ETF
PPA
$8.64B
$16.9K ﹤0.01%
200
OXY icon
223
Occidental Petroleum
OXY
$54.7B
$16.2K ﹤0.01%
275
-1,900
-87% -$114K
WY icon
224
Weyerhaeuser
WY
$18.4B
$16.1K ﹤0.01%
480
-224
-32% -$6.74K
XLP icon
225
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$15.9K ﹤0.01%
214

Similar funds

Bourgeon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bourgeon Capital Management held 360 positions worth $429M, up 2.1% from $420M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bourgeon Capital Management's Q2 2023 filing shows 39 new, 44 increased, 62 reduced and 23 closed positions. Its largest new stake was Teva Pharmaceuticals: 651,760 shares worth $4.91M. The largest sale was Jacobs Solutions, an estimated $7.04M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bourgeon Capital Management's largest Q2 2023 buy was Teva Pharmaceuticals: 651,760 shares worth $4.91M.
  • Bourgeon Capital Management added most to Teradyne in Q2 2023, an estimated $2.82M increase.
  • Bourgeon Capital Management's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $7.04M.
  • Bourgeon Capital Management fully exited Goldman Sachs MLP Energy Renaissance Fund in Q2 2023, selling an estimated $2.61M.
  • Bourgeon Capital Management's ten largest holdings make up 34% of its $429M portfolio in Q2 2023.
  • Bourgeon Capital Management opened 39 new positions and closed 23 in Q2 2023.
  • Bourgeon Capital Management's portfolio value rose 2.1% quarter-over-quarter to $429M.

Based on Bourgeon Capital Management's 13F filing for Q2 2023, filed 20 Jul 2023.